United Kingdom Periodontal Disease Market Size, Share, and COVID-19 Impact Analysis, By Type (Gingivitis, Chronic Periodontal Disease, Aggressive Periodontal Disease, Type 4, and Type 5), By Application (Non-surgical Treatment, Surgical Treatment, Application 3, Application 4, and Application 5), and United Kingdom Periodontal Disease Market Insights, Industry Trend, Forecasts to 2035

United Kingdom Periodontal Disease Market Insights Forecasts to 2035

• The United Kingdom Periodontal Disease Market Size Was Estimated at USD 172.21 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 6.04% from 2025 to 2035
• The United Kingdom Periodontal Disease Market Size is Expected to Reach USD 328.24 Million by 2035

According to a Research Report Published by Spherical Insights & Consulting, the United Kingdom Periodontal Disease Market Size is Anticipated to Reach USD 328.24 Million by 2035, Growing at a CAGR of 6.04% from 2025 to 2035. The increasing gum disease prevalence, aging populations, improved access to dental care, and increased awareness of oral health all contribute to the need for efficient periodontal evaluations and options for treatment.

Market Overview

The United Kingdom periodontal disease market  refers to the industry focused on the diagnosis, prevention, and treatment of periodontal disorders, which impact the gums and tooth support structures.  Pharmaceuticals, dental gadgets, and therapeutic methods utilized by dental practitioners are all included in this industry. An aging population, lifestyle choices, growing knowledge of oral health, and technology developments in dental care are the main drivers of growth, as they improve treatment results and increase demand for periodontal solutions. The increasing demand for cosmetic dentistry, greater awareness of the importance of good oral hygiene, and an aging population that is more susceptible to gum disease.  Improved care alternatives are provided by developments in dental technology, such as laser therapy and regenerative treatments. Furthermore, increasing access to dental insurance and implementing preventive care-focused public health programs encourage market expansion and create opportunities for new product and service offerings. AI-powered diagnostic instruments, biomaterials for tissue regeneration, and laser-assisted periodontal therapy.  Patient outcomes are improved by minimally invasive procedures and advanced antimicrobial therapies. In periodontal care, digital dentistry tools like intraoral scanners and 3D imaging also enhance accuracy, diagnosis, and treatment planning.

Report Coverage

This research report categorizes the market for the United Kingdom periodontal disease market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United Kingdom periodontal disease market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United Kingdom periodontal disease market.

Driving Factors

The increasing incidence of periodontal diseases brought on by smoking, poor dental hygiene, and lifestyle modifications greatly raises the need for efficient therapies. The senior citizen population's increased vulnerability to gum disease contributes to the market's expansion. Growing knowledge of oral health and how it relates to general health promotes early detection and preventive care.  Advances in technology, such laser therapy and regeneration procedures, increase the effectiveness of treatment and draw in more patients.  In addition, government programs encouraging oral health, expanding dental insurance coverage, and improving access to dental care services all support the market's steady expansion in the UK.

Restraining Factors

The high treatment expenses, a lack of patient understanding in some areas, and the invasiveness of some procedures that make patients reluctant. Overall growth and adoption rates are impacted by market expansion being constrained by regulatory barriers, reimbursement issues, and competition from alternative dental treatments.

Market Segmentation

The United Kingdom periodontal disease market share is classified into type and application.

• The gingivitis segment accounted for the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The United Kingdom periodontal disease market is segmented by type into gingivitis, chronic periodontal disease, aggressive periodontal disease, type 4, and type 5. Among these, the gingivitis segment accounted for the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. The segment growth is driven by a variety of factors, including increased smoking, widespread poor oral hygiene, growing awareness of early gum disease, and an increase in the need for non-surgical and preventative dental care. Frequent dental examinations also improve early diagnosis and treatment.

• The non-surgical treatment segment accounted for the largest revenue in 2024 and is expected to grow at a significant CAGR during the forecast period.

The United Kingdom periodontal disease market is segmented by application into non-surgical treatment, surgical treatment, application 3, application 4, and application 5. Among these, the non-surgical treatment segment accounted for the largest revenue in 2024 and is expected to grow at a significant CAGR during the forecast period. This is because of the increasing incidence of early-stage periodontal disease, improvements in preventative treatment methods including scaling, root planing, and laser-assisted therapies, patient preference for minimally invasive procedures, cost-effectiveness, and growing awareness of oral health.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom periodontal disease market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Bausch Health Companies Inc.
• Colgate-Palmolive Company
• Mylan N.V.
• Lyne Laboratories
• WOCKHARDT
• Xttrium Laboratories
• Sunstar Suisse S.A.
• 3M
• Izun Pharmaceuticals
• Tolmar Pharmaceuticals, Inc.
• Others

Recent Developments:

• In September 2023, Waken launched a Sonic Electric toothbrush featuring patented "Precision-power" technology, offering multiple cleaning modes and long-term rechargeable batteries, catering to consumers seeking advanced oral hygiene tools.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at UK, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United Kingdom periodontal disease market based on the below-mentioned segments:

United Kingdom Periodontal Disease Market, By Type

• Gingivitis
• Chronic Periodontal Disease
• Aggressive Periodontal Disease
• Type 4
• Type 5

United Kingdom Periodontal Disease Market, By Application

• Non-surgical Treatment
• Surgical Treatment
• Application 3
• Application 4
• Application 5